CT dose – optimising the risk to benefit ratio

M. Van Straten (, Netherlands)

Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis
Number: 4
Disease area: Paediatric lung diseases

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Van Straten (, Netherlands). CT dose – optimising the risk to benefit ratio. Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: